期刊文献+

甘油止痒乳剂的制备和质量控制研究

Preparation and Quality Control of the Glycerol Itching-relieving Emulsion
下载PDF
导出
摘要 目的探讨甘油止痒乳剂的制备及其质量控制方法。方法将水相和油相分别加热至75℃,在搅拌下将水相缓缓加入到油相中,待乳剂温度降至40℃以下时,加入苯酚和薄荷脑,搅拌至凝。采用紫外分光光度法测定其苯酚含量。结果苯酚最大吸收波长为270 nm,基质对其无干扰,苯酚含量在5.6~44.8μg/ml范围内与吸收度呈线性关系,吸光系数E11%cm为160.2(r=0.9999),平均回收率为98.99%。结论甘油止痒乳剂性质稳定,制备简便,质量控制方法准确、可靠。 Objective To explore the preparation and quality control of glycerol itching-relieving emulsion. Methods The aqueous phase and oil phase were heated to 75℃ respectively. Oil phase was added slowly into aqueous phase with stirring the mixture. The eutectic of phenol and menthol was added into when the emulsion temperature decreased below 40, and stirred the emulsion into coagulation. Phenol content was measured by ultraviolet spectrophotometry. Results The maximum phenol absorptive wavelength was 270 nm without the interference of groundplasm. Linear relationship was got between phenol content and absorbance when the range of phenol content was within 5.6-44.8 μg/ml. Absorption coefficient E1cm^1% was 160.2 (r = 0. 9999), and average recovery rate was 98.99%. Conclusion The glycerol itching-relieving emulsion is stable and it is easy to be preparated, so the quality control method is an accurate and reliable method.
出处 《解放军医药杂志》 CAS 2013年第2期69-71,共3页 Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
关键词 止痒药 药物调剂 质量控制 Antipruritics Drug compounding Drug Compounding Quality control
  • 相关文献

参考文献14

二级参考文献23

  • 1谢志强,杨高云,姜薇,徐敏丽.吡美莫司乳膏对成年女性面部皮炎快速抗瘙痒机制[J].中国医学科学院学报,2009,31(1):27-30. 被引量:10
  • 2李莉,梁刘萍,后桂荣,罗仁.加味玉屏风颗粒对变应性接触性皮炎NF-κB表达的影响[J].南方医科大学学报,2009,29(8):1582-1584. 被引量:6
  • 3杨洁,张之玮.瘙痒分型和发生机制的研究进展[J].中国煤炭工业医学杂志,2006,9(6):546-548. 被引量:3
  • 4丁媛,普雄明.瘙痒的发生机制、相关疾病和治疗[J].中国麻风皮肤病杂志,2006,22(6):492-495. 被引量:30
  • 5王洁.重视EGFRI相关皮肤不良反应[N].中国医学论坛报,2008-04-03(B5).
  • 6[1]V Peharda, F Gruber, M Kastelan, et al. Pruritus an important symptom of internal diseases [J]. Acta Dermatoven APA, 2000,3: 92-104.
  • 7[2]Szepietowski JC, Sikora M, Kusztal M, et al. Uremic pruritus: a clinical study of maintenance hemodialysis patients[J]. J Dermatol, 2002, 29(10): 621-627.
  • 8[1]De Conno FD,Caraceni A,Gamba A,et al.Pain measurement in cancer patients:a comparision of six methods.Pain,1994,57(2):161.
  • 9Boone SL, Rademaker A, Liu D, et al. Impact and management of skin toxicity associated with antl-epidermal growth factor receptor therapy : survey results [ J ] . Ontology, 2007, 72 (3-4) : 152- 159.
  • 10Waeker B, Nagrani T, Weinberg J, et al. Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase Ⅲ studies [ J ] . Clin Cancer Res, 2007, 13 ( 13 ) : 3913- 3921.

共引文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部